INTRODUCTION
The locus ceruleus (LC) provides the major source of noradrenaline (NA)-containing axons that are distributed widely throughout the central nervous system (CNS) (Berridge and Waterhouse, 2003) . This ubiquitous distribution is consistent with a prominent role for NA in a variety of CNS functions and behaviors that include locomotor control, cognition, motivation and attention (Berridge and Waterhouse, 2003) . In addition to these established transmitter signaling functions, NA evidently operates as an endogenous neurotrophic substance during development and adulthood (Meier et al., 1991; Colpaert, 1994; Goldstein, 2000 . For instance, pharmacological agents that mimic or increase NA release, such as α 2 adrenoceptor antagonists and amphetamine-related compounds reduced neuronal death in experimental models of cerebral ischemia and improved behavioral and functional recovery after brain injury (Goldstein, 2000) . Furthermore, increasing extracellular levels of NA by genetic invalidation of the NA transporter or by treatment with specific uptake inhibitors conferred protection to dopaminergic neurons in a mouse model of Parkinson disease (Rommelfanger et al., 2004) .
Conversely, lesions of the LC-NA system were shown to induce synaptic loss (Matsukawa et al., 2003) , aggravate post-ischemic cerebral damage (Goldstein, 2000) , increase brain inflammatory responses (Galea et al., 2003) or worsen neurological deficits in animal models of Parkinson disease (Marien et al., 1993) .
Although numerous theories for the cause of Alzheimer's disease (AD) and its symptoms have been postulated, it has most often been characterized as a disorder of progressive cholinergic deterioration. Studies of postmortem human brain have revealed a This article has not been copyedited and formatted. The final version may differ from this version. severe depletion of choline acetyltransferase (ChAT), the biosynthetic enzyme for acetylcholine, in the cortex and hippocampus, concomitant with the reduction in the number of basal forebrain cholinergic neurons (Mufson et al., 2003) . A number of observations suggest that the progressive nature of these cholinergic deficits might be influenced by the LC-NA system: (1) synapses between noradrenergic nerve terminals and cholinergic neurons are frequently encountered throughout basal forebrain areas including the vertical and horizontal limb of the diagonal band nuclei and the nucleus basalis magnocellularis (Fort et al., 1995) ; (2) there is a remarkably early and profound loss of NA cells in the LC in AD (Zarow et al., 2003) ; (3) stimulation of LC-NA output by the α 2 -adrenoceptor antagonist, dexefaroxan, affords protection in a retrograde lesion paradigm of basal forebrain cholinergic degeneration Chopin et al., 2004) .
To examine the neuroprotective potential of NA on basal forebrain cholinergic neurons, we have developed a model system in which rat septal cholinergic neurons in culture degenerate progressively when maintained in conditions that make them susceptible to low-level oxidative stress. Specifically, our aim was to use this model to (1) determine whether NA can prevent cholinergic cell death in vitro and to quantify its effects, (2) explore the possible mechanisms underlying this protection, and (3) examine whether trophic factors that are known to stimulate cholinergic differentiation and survival could modulate these effects. This article has not been copyedited and formatted. The final version may differ from this version. 
MATERIALS AND METHODS

Peptides and pharmacological agents
The L and D stereoisomers of NA (tartrate salts) were from Fluka (Saint Quentin Fallavier, France). Nerve growth factor 2.5S (NGF; Grade II) and brain derived neurotrophic factor (BDNF) were purchased from Alomone Labs (Jerusalem, Israel) and 
Cultures of septal cholinergic and LC noradrenergic neurons
Animals were treated in accordance with the Guide for the Care and Use of Laboratory Animals (National Research Council, 1996) , the European Directive N° 86/609, and the guidelines of the local institutional animal care and use committee. Septal cultures were prepared from embryonic day 15.5 Wistar rat embryos (Janvier Breeding Center; Le Genest St Isles, France). The septal area was dissected as described by Hartikka and Hefti (1988) . The dissected area contained cholinergic neurons that give rise to the medial septal nucleus and the nucleus of the diagonal band of Brocca (Hartikka and Hefti, 1988) . Tissue This article has not been copyedited and formatted. The final version may differ from this version. pieces were triturated mechanically without enzymatic treatment using modified L15 medium (Hartikka and Hefti, 1988) . Cultures were plated at a density of 2.5-3 x 10 5 cells/cm 2 and were maintained initially in 500 µL N5 medium (Kawamoto and Barrett, 1986 ) supplemented with 5 mM glucose, 5% horse serum (HS) and 0.5% fetal calf serum (FCS). Glial cell proliferation was prevented by gradually increasing the concentration of the anti-mitotic cytosine arabinoside (araC) according to the culture age (day in vitro, DIV) as follows: 1.5 µM (DIV 0), 3 µM (DIV 1-2) and 5 µM . In order to generate lowlevel oxidative stress, the N5 medium was replaced at DIV 10 with a chemically defined serum-free medium containing a trace amount of ferrous iron (0.5 µM). This medium consisted of MEM with Earle's salts (Invitrogen; Cergy Pontoise, France) and Ham's F12 nutrient mixture (2V:1V; Invitrogen) supplemented with insulin (10 µg/mL), glucose (30 mM), penicillin and streptomycin (100 U/mL). Since neurons were grown in an astrocytepoor environment that favors excitotoxic stress, the non-competitive NMDA receptor antagonist dizocilpine (MK-801; 3 µM) was also added to the culture medium from DIV 3 until the end of the culture period. Unless specified, 50 ng/mL NGF was used to supplement the culture media in order to stimulate cholinergic differentiation. Some experiments were also performed with BDNF at a final concentration of 20 ng/mL. dissected corresponded to the whole proximal rhombencephalic ring between the distal part of the mesencephalic flexure and the proximal part of the pontine flexure (Holm et al., 2003) . After trituration, the cells were plated at a density of 3-4 x 10 5 cells/cm 2 and then maintained for 9-10 days in a culture medium consisting of MEM with Earle's salts and Ham's F12 nutrient mixture (1V:1V) supplemented with FCS (0.5%), N2 cocktail (1x; Invitrogen), BDNF (20ng/mL), glucose (30 mM), penicillin and streptomycin (100 U/mL), and 3µM MK-801. AraC (1.5µM) was added between DIV 1-3 to limit glial cell proliferation.
Acetylcholine esterase cytochemistry
Acetylcholine esterase (AChE) cytochemistry was performed as previously described (Michel and Agid, 1995) . Briefly, after fixation with 4% formaldehyde and three washes with Dulbecco's phosphate-buffered saline (D-PBS) the cultures were incubated at 4°C in 50 mM acetate buffer, pH 5.0, containing 4 mM acetylthiocholine iodide, 2 mM copper sulfate, 10 mM glycine and 10 mg/mL gelatin to prevent diffusion of the reaction products.
Nonspecific choline esterases were inhibited by 0.2 mM ethopropazine. After 3-4 days, the gelatin was dissolved by briefly incubating the cultures at 37°C. The cultures were rinsed with distilled water and exposed for 30 min in 10% potassium ferricyanide. The reaction was stopped by washing with distilled water.
Choline acetyltransferase immunodetection
Cultures fixed with 4% formaldehyde were incubated for 4 days at 4°C with a choline acetyltransferase (ChAT) monoclonal antibody (1:50 in D-PBS) derived from a rat This article has not been copyedited and formatted. The final version may differ from this version. (Diasorin, Stillwater, MN, USA) . Subsequent incubations were performed at room temperature with a biotinylated anti-rat Ig antibody from goat (1:100 in D-PBS, Amersham Biosciences, Orsay, France), followed by amplification with a preformed avidinbiotin horseradish peroxidase complex (Vectastain, Vector, Burlingame, CA). The peroxidase was revealed by incubation with a solution of diaminobenzidine (0.5 mg/mL) in D-PBS containing 0.0075 % hydrogen peroxide (H 2 O 2 ). The reaction was stopped by two rapid washes with D-PBS.
Measurement of ChAT activity
ChAT activity was measured by the method described by Hartikka and Hefti (1988) with minor modifications. Briefly, the cultures were washed three times with D-PBS and lysed at 4°C with 250 µL/well of 50 mM Tris-HCl buffer, pH 6, containing 0.3% Triton-X-100. Aliquots (50 µL) of the lysate were mixed with 100 µL of a solution containing 30 mM choline chloride, 0.6 mM eserine hemisulfate, 900 mM NaCl and 150 mM Na 2 HPO 4 . The reaction was initiated by addition of 50 µL of a 10 mM sodium phosphate buffer, pH 7.4, containing [1-14 C]-acetyl-coenzyme-A diluted with unlabelled acetyl-CoA to give a final substrate concentration of 20 µM (specific activity 4 mCi/mmol). Radioactivity corresponding to the reaction product ([ 14 C]-ACh) was measured by organic liquid scintillation counting. Note that the rate of ChAT activity was linear with time and amount of cell homogenate added.
Quantification of reactive oxygen species (ROS)
The production of mitochondrial reactive oxygen species (ROS) was quantified This article has not been copyedited and formatted. The final version may differ from this version. Troadec et al. (2002) . Briefly, septal cultures were exposed for 30 min to 50 µM DHR-123, washed 3 times and then maintained in serum-free medium supplemented with the test treatments. The fluorescent signal, visualized by epifluorescence microscopy (excitation 488 nm, emission 515 nm), was quantified using the Simple-PCI 
Detection of caspase activation
CaspACE TM -FITC-VAD-FMK In Situ Marker was added directly to the cultures at a final concentration of 10 µM in the presence of the test treatments. After incubation for 20 min at 37°C, the cultures were washed three times and then maintained with the test treatments during examination. The fluorescent signal was visualized by epifluorescence microscopy using the same filters as for DHR-123. Fluorescent cells were counted in 20-30 fields using a 40x objective. This article has not been copyedited and formatted. The final version may differ from this version. 
Quantification and visualization of [ 3 H]-NA uptake
Intraneuronal accumulation of NA via active transport was monitored in septal and LC cultures using a protocol adapted from Troadec et al. (2002) . Briefly, after preincubation for 10 min in 500 µl of PBS containing 5 mM glucose and 100 µM ascorbic acid, the uptake was initiated by addition of 50 nM [ 3 H]-NA (37 Ci/mmol) to the cultures and terminated after 15 min by removal of the incubation medium followed by two rapid washes with cold PBS. Cells were scraped off the culture wells and counted by liquid scintillation spectrometry. When the accumulation of [ 3 H]-NA was visualized by microautoradiography, the incubation time with [ 3 H]-NA was extended to 30 min. After two rapid washes with PBS, the cultures were fixed for 20 min in PBS containing 0.5% glutaraldehyde and 4% formaldehyde, and dehydrated with ethanol. The incorporation of the tritiated label was detected with the Hypercoat LM-1 emulsion (Amersham Biosciences) after an exposure of 8-10 days in the dark at 4°C. Blockade of NA saturable transport was obtained in the presence of 0.5 µM desipramine.
Statistical analysis
Comparisons between two groups were performed with Student's t-test. Multiple comparisons against a single reference group were made by one-way analysis of variance 
RESULTS
NA provides long-lasting protection to cholinergic neurons
In the model system used here, rat septal cholinergic neurons were maintained initially for 10 days in a culture environment that favors their maturation and differentiation, and then exposed to trace amounts of ferrous iron to stimulate low-level oxidative stress. In the first 3-4 days that followed the initiation of the treatment with iron, no noticeable morphological changes were detectable and the number of cholinergic neurons assessed by AChE cytochemistry remained virtually unchanged ( Fig. 1A) . After DIV 14, however, AChE + neurons began to degenerate progressively such that > 90% had died by DIV 16 (Fig. 1A ). When NA (5 µM) was applied from DIV 10 onwards, the loss of AChE + neurons was completely prevented ( Fig. 1A; Fig. 2 top panel) . The survivalpromoting effects of NA could be extended to at least DIV 20. When the addition of iron was made at DIV 13 instead of DIV 10, the loss of cholinergic neurons did not occur between DIV 14-16 as observed previously but between DIV 18-20 which suggests (1) that neuronal demise was not dependent on a specific stage of maturation of the cultures and (2) that a period of at least 3-4 days was required to initiate the degenerative process in the presence of the transition metal. In this paradigm, NA provided again robust protection to cholinergic neurons (Fig. 1A ). Note that in subsequent experiments made with septal cultures, treatments with iron were initiated at DIV 10.
AChE cytochemistry is a reliable and sensitive marker to detect and quantify cholinergic neurons in septal cultures (Hartikka and Hefti, 1988; Michel and Agid, 1995) .
However, to confirm and extend our initial observation we also counted ChAT + cells at DIV 17, i.e. at a time when extensive cell loss was occurring in control cultures exposed to iron This article has not been copyedited and formatted. The final version may differ from this version. first at DIV10. ChAT + cell counts revealed that the survival promoting effect of NA was concentration-dependent with an EC 50 of ~ 0.3 µM ( Fig. 1B) . Maximal effects were observed in the range of concentrations between 1-5 µM (Fig. 1B) . ChAT + neurons exposed to NA were well differentiated ( Fig. 2 bottom panel Consistent with the results obtained by cell counting, NA prevented the loss in ChAT enzymatic activity associated with neuronal demise (Fig. 1B) , indicating that cholinergic neurons rescued by NA remained functional. Finally, phase contrast examination of the cultures revealed that NA was also effective in providing neuroprotection to non-cholinergic (mostly GABAergic) neurons in septal cultures (data not shown).
The effects of NA on cholinergic neuronal survival are independent of adrenoceptors
We compared the neuroprotective potential of NA to that of selective agonists of adrenoceptors. Neither α 1 , α 2 (phenylephrine and UK14,304, respectively) nor β 1 , β 2 , (xamoterol and procaterol, respectively) adrenoceptor agonists each used at 5µM were able to substitute to NA treatment (Fig.3A ). In addition, no survival promoting effect was detectable when phenylephrine and UK14,304 or xamoterol and procaterol treatments were combined. Accordingly, the protective effect of NA (2µM) was antagonized neither by phentolamine (2 µM) nor by propanolol (2 µM), two prototypical antagonists of αand β-This article has not been copyedited and formatted. The final version may differ from this version. adrenoceptors, respectively, indicating that NA acted by a mechanism that presumably circumvented adrenoceptors ( Fig. 3B ). There were two other strong arguments in favor of this hypothesis; (1) the D stereoisomer of the neurotransmitter which is not active at the adrenoceptor site (Hearse and Sutherland, 1999) was as protective as the naturally occurring L form [the form used throughout the manuscript except when specified]; (2) pyrocatechol, a compound that reproduces the structure of the diphenolic moiety of NA but lacks significant binding affinity for adrenoceptors (Vauquelin et al., 1979) mimicked in a concentration-dependent manner the protective effects of the neurotransmitter for cholinergic neurons (Fig. 3C ).
NA rescues cholinergic neurons by preventing oxidative stress
Because the neuroprotective effect of NA for cholinergic neurons appeared to be independent of adrenoceptor activation, we examined the nature of other putative mechanisms of action. The survival promoting activity of NA was mimicked by trolox (10 µM), a cell-permeable water-soluble derivative of vitamin E, suggesting that NA itself behaved as an antioxidant (Fig. 4A ). The use of the fluorescent probe DHR-123 revealed that NA was indeed as potent as trolox in reducing ROS production in degenerating septal neurons ( Fig. 4B ) and in particular in the population of magnocellular cholinergic neurons ( Fig. 4C ). Pyrocatechol and the D stereoisomer of NA which were as potent as NA in protecting cholinergic neurons ( Fig. 4A and also Fig. 3 ) were also highly effective in reducing intracellular ROS production in our culture model (Fig. 4B ). However, two other antioxidants, vitamin-C 2-phosphate (100 µM), a stable form of vitamin C, and N-acetyl cysteine (NAC; 5 mM), the precursor of reduced glutathione, both failed to provide This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 4A ). In addition, vitamin-C and NAC were also totally ineffective in reducing oxidative stress in the present paradigm (Fig. 4B ). Finally, GABA, a neurotransmitter that is structurally unrelated to NA in that it does not possess a catechol ring, was totally ineffective in reducing ROS levels and in rescuing cholinergic neurons from degeneration.
Besides trolox and pyrocatechol, iron chelators such as desferrioxamine (10 µM) and apotransferrin (100 µg/mL) reproduced the neuroprotective action of NA (Fig. 5A ).
Neuroprotection with desferrioxamine and apotransferrin was associated with a decrease in the production of intracellular ROS similar to that obtained with NA (5 µM) (Fig. 5B ). This demonstrates that NA prevented a degenerative process initiated by iron which is present at a low concentration in our culture medium. Consistent with this observation, cholinergic neurons were resistant to degeneration when maintained with the same culture medium formulated without iron (not shown). Interestingly, catalase (300 UI/mL), an enzyme known to prevent iron-catalyzed Fenton type chemistry afforded a degree of protection and a reduction in the emission of intracellular ROS similar to that provided by NA (Fig. 5 ).
NA provides neuroprotection without being accumulated intracellularly
Blocking NA uptake with desipramine, a selective inhibitor of the high affinity NA transport system, was reported previously to prevent the trophic effects of NA in another model system (Zhang et al., 1997) . This led us to speculate that the neuroprotective and thus antioxidant-like effect of NA might result from its accumulation into cholinergic neurons by active transport. Such a mechanism was, however, apparently not involved in the present model system. Indeed, in septal cultures there was no detectable desipramine-sensitive NA This article has not been copyedited and formatted. The final version may differ from this version. uptake, at variance to what we observed in a culture system that contains NA neurons, i.e., LC cultures (Fig. 6A ). Consistent with these observations, microautoradiographic studies revealed that the tritiated label was virtually absent from cholinergic neurons and other neurons in septal cultures (Fig. 6B,C) but readily detectable in LC NA neurons and their processes (Fig. 6D ). Not surprisingly, desipramine (0.5 µM) was unable to reduce the survival promoting action of NA (1µM) for cholinergic neurons (Fig. 6E) 
At what stage of the degenerative process does the presence of NA become critical as a protective factor?
Experiments were carried out to determine whether the onset of cholinergic cell loss was preceded by a progressive accumulation of intracellular ROS (i.e., before DIV 14), and whether the antioxidant effect of NA was detectable during this time. ROS were measured in DIV 13 and DIV 15 cultures in the absence and presence of NA (5 µM). An increased production of ROS was observed only when the cell death process was truly engaged and not before (Fig. 7A) ; accordingly, the antioxidant effect of NA was evident only during the stage when cell demise was occurring in the cultures. This might explain why NA could be protective to cholinergic neurons even if its application was delayed up to DIV 15 ( Fig.   7B ).
Protection of cholinergic neurons by NA occurs via inhibition of a caspase-dependent
This article has not been copyedited and formatted. The final version may differ from this version. To further characterize the neuroprotective mechanisms of NA in our model, a possible involvement of proapoptotic caspases in cholinergic neuronal death was examined.
For that reason, we compared the survival promoting effect of NA to that of several caspase inhibitors; Z-DEVD-FMK (100 µM), a broad-range cell permeable caspase inhibitor, Z-IETD-FMK (50µM), a specific inhibitor of caspase-8 and Z-LEHD-FMK (100 µM), an inhibitor that is relatively specific for caspase-9. Z-IETD-FMK mimicked completely the neuroprotective effect of NA, while Z-DEVD-FMK was partially protective and Z-LEHD-FMK completely ineffective ( Fig. 8A ). Of note, the neuroprotective action of Z-IETD-FMK was not additive to that produced by NA (not shown), suggesting that both compounds acted by preventing a common cell death pathway.
A more direct approach to test for caspase involvement was taken by exposing the cultures to CaspACE TM FITC-VAD-FMK (10 µM), a cell permeable pan-caspase fluorogenic substrate. Visual examination of control cultures revealed the presence of a strong fluorescent signal in 8-12% of neuronal cells ( Fig. 8B and 8C) , particularly in those neurons exhibiting evident morphological changes. The number of cell bodies labeled by CaspACE TM FITC-VAD-FMK was dramatically reduced by the presence of NA or Z-IETD-FMK, attesting to the reduction of caspase activity by the neurotransmitter (Fig. 8B and   8C ). Interestingly, the use of DHR-123 revealed that caspase inhibition by Z-IETD-FMK was also very effective in preventing ROS production in septal neurons and more specifically so in the population of magnocellular neurons exhibiting the typical morphology of cholinergic neurons ( Fig. 8D and 8E ). This article has not been copyedited and formatted. The final version may differ from this version. 
Is the neuroprotective action of NA modulated by NGF?
In our model, the neurotrophin NGF was provided in basal conditions in order to stimulate the differentiation of cholinergic neurons. To determine whether NGF influenced the neuroprotective action of NA, we assessed the efficacy of a treatment with NA (DIV 10-17) on cholinergic neurons maintained throughout their lifespan in the absence of the neurotrophin. NA had the same efficacy in preserving cholinergic neuronal numbers in the absence of NGF (Fig. 9A ), suggesting that the survival promoting action of NA was not dependent on NGF. It is noteworthy that when NA was absent from the culture medium, NGF was totally ineffective in protecting cholinergic neurons from degeneration. However,
NGF dramatically increased the proportion of cholinergic neurons expressing high levels of
ChAT in NA-treated cultures, indicating that the capacity of this factor to stimulate ChAT expression was dependent on the presence of the neurotransmitter. The proportion of cells expressing high levels of ChAT was the same regardless of whether the NA treatment was initiated at DIV 1 or DIV 10 (data not shown). In line with these findings, ChAT enzymatic activity was at least threefold higher in the presence of NGF and NA compared to NA alone ( Fig. 9B ). Furthermore, cholinergic neurons treated with NGF and NA had cell bodies that were larger in size than those treated with NA alone (Fig. 9C) .
BDNF, another neurotrophin known to promote the development and maintenance of cholinergic neurons (Knusel et al., 1992) , was examined under similar experimental conditions in order to determine whether it too could influence the protective effects of NA.
Similar to what was observed in NGF/NA-treated cultures, the large majority of cholinergic neurons rescued by cotreatment with BDNF and NA expressed high levels of the ChAT enzyme ( Fig. 9A and 9C) . These neurons were, however, smaller in size than those treated This article has not been copyedited and formatted. The final version may differ from this version. with NGF and NA (Fig. 9C) . Consistent with this finding, BDNF was also less effective than NGF in stimulating ChAT activity in the presence of NA (Fig. 9B) . Importantly, and like NGF, BDNF failed to increase cholinergic cell survival in the absence or the presence of NA (Fig. 9A) .
DISCUSSION
Here, we demonstrate that NA provides sustained and robust neuroprotection in a model system of septal cholinergic cell death in vitro. Importantly, rescued cholinergic neurons were functional and well preserved morphologically. Neuroprotection by NA was atypical in that it did not require adrenoceptor activation. NA evidently operated through a mechanism that precludes activation of a ROS-dependent cell death pathway. Neither NGF nor BDNF alone were able to mimic the protective action of NA, although both neurotrophins appeared dependent on the presence of the neurotransmitter to reinforce the expression of the cholinergic phenotype.
NA protects cholinergic neurons from oxidative stress caused by a Fenton-type reaction
Several observations indicate that NA operates in our model by reducing oxidative stress: (1) cholinergic neurons were protected efficiently by an analog of vitamin E trolox and by pyrocatechol, a diphenolic compound with a strong antioxidant capacity (Troadec et al., 2002) ; (2) the rescue of cholinergic neurons was also achieved by desferrioxamine and apotransferrin two molecules known to sequester iron, a transition metal catalyst for the Fenton reaction which allows the conversion of H 2 O 2 into highly reactive hydroxyl radicals (Halliwell and Gutteridge, 1984) and (3) neuroprotective. The finding that NA reduced to a large extent ROS emission within septal neurons, and in particular in the population of cholinergic neurons, confirmed that NA was operating by preventing oxidative stress or its consequences. The antioxidant function of NA was apparently not mediated by activation of membrane located adrenoceptors. It appeared to be related, however, to the presence of a catechol moiety in its chemical structure since (1) its effects were reproduced in a concentration dependent manner by the structural congener pyrocatechol (the o-catechol moiety of NA), and (2) GABA, a neurotransmitter with no catechol ring, was totally ineffective in reducing ROS levels and rescuing cholinergic neurons.
NA operates via an extracellular mechanism
Both the protective and antioxidant effects of NA for cholinergic neurons were mimicked by chronic treatment with catalase, an enzyme that neutralizes ROS exclusively in the extracellular compartment since it cannot penetrate the plasma membrane of intact cells (Muzykantov, 2001) . Several observations would suggest that the site of the antioxidant effect of NA was, like that of catalase, extracellular. Firstly, neuroprotection by NA was independent of adrenoceptors, ruling out an antioxidant effect resulting from the activation of intracellular signaling pathways. Secondly, accumulation of NA via active transport has been described in PNS developing cholinergic neurons (Habecker et al., 2000) , but we found that this mode of transport was absent in basal forebrain cholinergic neurons. Thirdly, the possibility that the accumulation of NA or its potential metabolites occurred by passive transport is also unlikely since even after chronic exposure to [ 3 H]-NA we failed to detect substantial amounts of radioactive label within cholinergic neurons as This article has not been copyedited and formatted. The final version may differ from this version. well as other septal neurons. Therefore, we may surmise that the action of the neurotransmitter consisted in preventing the propagation of oxidative stress at the level of the outer plasma membrane, thus precluding ROS from being generated intracellularly.
Consistent with this view, NA has been shown to prevent the peroxidation of membrane lipids in cell-free systems (Andorn and Pappolla, 2001) . We can not exclude that iron scavenging by the neurotransmitter represented the underlying chemical mechanism. Based on previous studies performed with other catechol derivatives (Stites et al., 2000) it is also conceivable, however, that redox-cycling between NA and its autoxidation product NAquinone participated to neuroprotection.
When do cholinergic neurons require the presence of NA to survive?
Surprisingly, the death of cholinergic neurons did not occur immediately following addition of iron to the cultures at DIV 10 but only after a delay of 3-4 days. It may be that cholinergic neurons become susceptible to oxidative stress upon reaching some critical stage just prior to DIV 15-16 in culture, although this seems unlikely since a comparable delay prior to neurodegeneration was observed when the treatment with iron was postponed by several days. Alternatively, as a consequence of the treatment with iron, intracellular ROS might accumulate progressively before reaching levels sufficient to kill cholinergic cells. If this were the case, one would expect NA to suppress intracellular ROS production during that time. Arguing against this hypothesis, ROS levels were identical in NA-treated and control cultures before the onset of cholinergic cell degeneration. It cannot be excluded that NA protected the plasma membrane of cholinergic neurons from oxidative stressmediated damage long before an increase in ROS levels was detectable intracellularly. The fact that NA was still able to effectively interrupt the degenerative process even when This article has not been copyedited and formatted. The final version may differ from this version. applied several days after placing the cultures in a ROS-producing environment indicates that these alterations if they occurred were still reversible in the presence of the neurotransmitter.
NA reduces intracellular ROS production via inhibition of a caspase-dependent mechanism
Two arguments suggest that caspases, i.e., proteases that mediate apoptotic cell death (Hengartner, 2000) , were crucially involved in the death pathway inhibited by NA; (1) Z-IETD-FMK, a selective inhibitor of caspase-8 and Z-DEVD-FMK a broad-range caspase inhibitor reproduced totally and partially, respectively the protective effect of NA; (2) NA itself prevented caspase activation. Given that the site of action of NA was presumably extracellular, caspase inhibition produced by the neurotransmitter was most likely indirect.
Activation of caspase-8 and other caspases is frequently caused by stimulation of the death domain receptor Fas (FasR) by its cognate ligand FasL (Qiu et al., 2002) suggesting that NA might prevent a FasR-related mechanism. This appears unlikely, however, since cholinergic neurons were resistant to a soluble recombinant FasL protein and a FasL recombinant neutralizing antibody failed to reproduce neuroprotection by NA (not shown). It is worth noting that the reduction of oxidative stress produced by the inhibitor of caspase-8 in cholinergic neurons was similar to that obtained with NA which indicates that intracellular ROS were probably generated downstream of the level at which the caspase-dependent mechanism intervenes. Interestingly, a recent study has linked mitochondrial ROS production during apoptosis to caspase-dependent cleavage of a complex I subunit of the mitochondrial electron transport chain (Ricci et al., 2004) . This article has not been copyedited and formatted. The final version may differ from this version. 
NA provides optimal neuroprotection even in the absence of NGF
Unlike dopaminergic neurons which were only protected partially against oxidative stress by NA [~40% of them were rescued after 10 days of treatment (Troadec et al., 2001) ], virtually all septal cholinergic neurons survived to ROS-mediated damage in the presence of the neurotransmitter. Such a difference may lie in the fact that NGF present continuously for the differentiation and maturation of cholinergic neurons may have already enhanced the survival promoting effects of NA in the same way as cAMP elevating agents improved the effects of the neurotransmitter for dopaminergic neurons in mesencephalic cultures (Troadec et al., 2002) . Supporting this view, NGF can attenuate the deleterious consequences of oxidative stress-mediated neuronal injuries in some culture models (Salinas et al., 2003) and conversely, mitochondrial-derived ROS are produced in NGFresponsive neurons that are deprived of the neurotrophin (Kirkland and Franklin, 2003) . To determine whether NGF improved the neuroprotective action of NA on cholinergic neurons, we performed experiments with cultures maintained throughout their lifespan without the neurotrophin. Despite the absence of NGF, NA alone was sufficient to rescue virtually all cholinergic neurons susceptible to degeneration. This indicates that NGF was not essential for survival promotion by NA. Consistent with this observation, NGF was unable to promote cholinergic cell survival or to reduce ROS production in the absence of NA.
Therefore, the presence of NGF cannot account for the high efficacy of NA to rescue septal cholinergic neurons. This article has not been copyedited and formatted. The final version may differ from this version. 
NGF and BDNF retain their capacity to stimulate cholinergic parameters in the presence of NA
Even though NGF lacked survival-promoting effects either by itself or in the presence of NA, it did improve the impact of NA by increasing ChAT expression and cell size in surviving cholinergic neurons. BDNF, another neurotrophin known to function as a trophic factor for cholinergic neurons (Knusel et al., 1992) , had a similar but somewhat less pronounced effect than NGF. That exogenous NGF and BDNF were able to stimulate cholinergic parameters exclusively in the presence of NA is noteworthy, since a number of diphenolic antioxidants have been shown to interfere with the function of some regulatory peptides or cytokines (Zi et al., 1998) . Our results are more consistent with studies showing that NA can act cooperatively with trophic peptides such as glial cell line-derived neurotrophic factor and ciliary neurotrophic factor on specific populations of neurons in the brain (Louis et al., 1993; our unpublished data) .
Recent studies support the idea that proapoptotic caspases (Rohn et al., 2001; Cribbs et al., 2004) and ROS-mediated reactions (Casadesus et al., 2004; Patrico and Sung, 2004) are crucially involved in neurodegeneration in AD. Our results showing that NA can substantially reduce both caspase activation and ROS production in cholinergic neurons, one of the neuronal populations most at risk in AD, provide support to the concept that compounds which stimulate NA output may have therapeutic utility in the treatment of this pathology. This article has not been copyedited and formatted. The final version may differ from this version. 
